首页|阿奇霉素治疗小儿肺炎支原体肺炎的临床疗效观察

阿奇霉素治疗小儿肺炎支原体肺炎的临床疗效观察

扫码查看
目的:探讨阿奇霉素治疗小儿肺炎支原体肺炎的作用。方法选择78例支原体肺炎儿童患者,随机分成阿奇霉素组36例和红霉素组42例,分别用阿奇霉素和红霉素进行抗肺炎支原体治疗。结果阿奇霉素组在平均退热天数、咳嗽消失天数、胸片阴影完全吸收天数(平均治愈天数)均较红霉素组缩短,其治愈率及总有效率明显高于红霉素组。不良反应发生率明显减少。结论阿奇霉素治疗小儿肺炎支原体肺炎疗效优于红霉素,值得进一步推广与探讨。
Objective Explore pediatric azithromycin treatment mycoplasma pneumonia role Methods Choose 78 cases of mycoplasma pneumonia patients with children, Random into 36 cases and erythromycin azithromycin group group 42 cases, Azithromycin and erythromycin were used to fight mycoplasma pneumoniae treatment. Result The average number of azithromycin fever 、Cough disappeared days、Chest radiograph shadow completely absorbed days (average cure days) Than erythromycin group reduced. The cure rate and the total effective rate was higher than erythromycin group. Adverse reaction rate for significantly less. Results Azithromycin treatment infantile pneumonia mycoplasma pneumonia better therapeutic erythromycin, Is worth further promotion and discussion.

AzithromycinErythromycinChildrenMycoplasma pneumoniae pneumonia

赵远贵、孙世军

展开 >

山东省青州市人民医院 262500

阿奇霉素 红霉素 小儿 肺炎支原体肺炎

2014

中外健康文摘
中国中医药报社

中外健康文摘

影响因子:0.016
ISSN:1672-5085
年,卷(期):2014.(17)
  • 3